Digital Mammography Screening Trial (ACRIN6652)

Study Overview
=================
Brief Summary
-----------------
RATIONALE: Screening tests may help doctors detect cancer cells early and plan more effective treatment for cancer. It is not yet known which type of mammography is more effective in detecting breast cancer. PURPOSE: Screening and diagnostic trial to compare the effectiveness of two types of mammography in detecting breast cancer in women.

Detailed Description
-----------------
OBJECTIVES: Compare the diagnostic performance of digital mammography vs screen-film mammography, as measured by the area under the Receiver Operating Characteristic (ROC) curve, sensitivity, specificity, and positive and negative predictive values, in the detection of breast cancer in women. Compare the diagnostic accuracy of the digital mammogram obtained using each of the individual manufacturer's digital units vs screen-film mammography through retrospective reader studies. Determine the effects of patient characteristics, including age, lesion type, pathologic diagnosis, menopausal and hormonal status, breast density, and family history, on diagnostic accuracy of digital mammography. Determine the effects of technical parameters, including display type, machine type, and detector spatial and contrast resolution, on diagnostic accuracy of digital mammography. Determine the effect of reduced false-positive mammograms that are expected with digital mammography on the health-related quality of life and personal anxiety of women undergoing this screening experience. Compare the diagnostic performance of digital mammography with the rate of cancer in a set of cases through a retrospective reader study. Compare the effect of softcopy vs printed film display on the diagnostic performance of digital mammography through a retrospective reader study. Compare the effect of breast density on the diagnostic accuracy of digital mammography vs screen-film mammography through a retrospective reader study. Compare the image quality and breast radiation dose in digital vs screen-film mammography in these participants. Determine the temporal variations in image quality, breast radiation dose, and other quality control parameters in the participating study centers. OUTLINE: This is a randomized, multicenter study. Participants with postitive screening results are stratified according to age (under 50 vs 50-59 vs 60-70 vs over 70). Participants are randomized to one of two treatment arms. Arm I: Participants undergo a two-view screen-film mammogram followed by a two-view digital mammogram of each breast. Arm II: Participants undergo a two-view digital mammogram followed by a two-view screen-film mammogram of each breast. Quality of life is assessed before the screening mammogram in the first 800 women enrolled. In an additional 1,200 participants (600 with positive screening results and 600 with negative screening results), quality of life is assessed shortly after the screening mammogram and at 1 year. Participants are followed at 1 year with a repeat screen-film or digital mammogram. PROJECTED ACCRUAL: A total of 49,500 participants (24,750 per arm) will be accrued for this study within 18 months.

Official Title
-----------------
Screening and Diagnostic Trial to Compare the Effectiveness of Two Types of Mammography in Detecting Breast Cancer in Women

Conditions
-----------------
Breast Cancer

Intervention / Treatment
-----------------
* Diagnostic Test: Full Field Digital Mammography
* Diagnostic Test: Screen Film Mammography


Participation Criteria
=================
Eligibility Criteria
-----------------
4.1 Inclusion Criteria 4.1.1 All consecutive women presenting for screening mammography at the participating institutions will be eligible. 4.1.2 Signed study-specific informed consent. See Appendix I. 4.2 Exclusion Criteria 4.2.1 All women who have presented with a complaint of a focal dominant lump or a bloody or clear nipple discharge. 4.2.2 All women who have breast implants. 4.2.3 Any woman who is pregnant or has reason to believe that she might be pregnant. 4.2.4 Participants who cannot, for any reason, undergo follow-up screen-film mammography at the participating institution or provide mammograms from another institution for review for one year after study entry. 4.2.5 All women with a history of breast cancer treated with lumpectomy. Note: Women with a history of breast cancer treated with mastectomy who have now returned to a screening population will still be included in the study.

Ages Eligible for Study
-----------------
Maximum Age: 120 Years

Sexes Eligible for Study
-----------------
Female

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Screening
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Other: SFM then FFDM<br>Screen Film Mammography (SFM) followed by Full Field Digital Mammography (FFDM) | Diagnostic Test: Full Field Digital Mammography<br>* Radiologic test to screen women for Breast cancer using digital detectors<br>* Other names: Digital Mammography;Diagnostic Test: Screen Film Mammography<br>* Radiologic test to screen women for Breast cancer using plain film detectors a resolution screen<br>* Other names: Plain Film Mamography;|
| Other: FFDM then SFM<br>Full Field Digital Mammography (FFDM) followed by Screen Film Mammography (SFM) | Diagnostic Test: Full Field Digital Mammography<br>* Radiologic test to screen women for Breast cancer using digital detectors<br>* Other names: Digital Mammography;Diagnostic Test: Screen Film Mammography<br>* Radiologic test to screen women for Breast cancer using plain film detectors a resolution screen<br>* Other names: Plain Film Mamography;|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
breast cancer